Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium

Autor: Trabert, Britton, Ness, Roberta B, Lo-Ciganic, Wei-Hsuan, Murphy, Megan A, Goode, Ellen L, Poole, Elizabeth M, Brinton, Louise A, Webb, Penelope M, Nagle, Christina M, Jordan, Susan J, Australian Ovarian Cancer Study Group, Australian Cancer Study Ovarian Cancer, Risch, Harvey A, Rossing, Mary Anne, Doherty, Jennifer A, Goodman, Marc T, Lurie, Galina, Kjær, Susanne K, Hogdall, Estrid, Jensen, Allan, Cramer, Daniel W, Terry, Kathryn L, Vitonis, Allison, Bandera, Elisa V, Olson, Sara, King, Melony G, Chandran, Urmila, Anton-Culver, Hoda, Ziogas, Argyrios, Menon, Usha, Gayther, Simon A, Ramus, Susan J, Gentry-Maharaj, Aleksandra, Wu, Anna H, Pearce, Celeste Leigh, Pike, Malcolm C, Berchuck, Andrew, Schildkraut, Joellen M, Wentzensen, Nicolas, Ovarian Cancer Association Consortium

Publikováno v: Trabert, Britton; Ness, Roberta B; Lo-Ciganic, Wei-Hsuan; Murphy, Megan A; Goode, Ellen L; Poole, Elizabeth M; et al.(2014). Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.. Journal of the National Cancer Institute, 106(2), djt431. doi: 10.1093/jnci/djt431. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/21n5w6kv

BACKGROUND:Regular aspirin use is associated with reduced risk of several malignancies. Epidemiologic studies analyzing aspirin, nonaspirin nonsteroidal anti-inflammatory drug (NSAID), and acetaminophen use and ovarian cancer risk have been inconclus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::a3a1739849d78ba6044de2b9dacb4944
http://www.escholarship.org/uc/item/21n5w6kv